ECSP961634A - AGONISTS, ESTROGEN ANTAGONISTS - Google Patents

AGONISTS, ESTROGEN ANTAGONISTS

Info

Publication number
ECSP961634A
ECSP961634A ECSP961634A ECSP961634A EC SP961634 A ECSP961634 A EC SP961634A EC SP961634 A ECSP961634 A EC SP961634A EC SP961634 A ECSP961634 A EC SP961634A
Authority
EC
Ecuador
Prior art keywords
agonists
estrogen antagonists
diseases
estrogen
antagonists
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Robert L Rosati
Kimberly O'keefe Cameron
Jardine Paul A Dasilva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961634 priority Critical patent/ECSP961634A/en
Publication of ECSP961634A publication Critical patent/ECSP961634A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos de fórmula: Utiles para el tratamiento o prevención de la obesidad, cáncer de mama, osteoporosis, endometriosis, enfermedades cardiovasculares y enfermedades prostáticas.Compounds of formula: Useful for the treatment or prevention of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular diseases and prostate diseases.

ECSP961634 1996-01-09 1996-01-09 AGONISTS, ESTROGEN ANTAGONISTS ECSP961634A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961634 ECSP961634A (en) 1996-01-09 1996-01-09 AGONISTS, ESTROGEN ANTAGONISTS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961634 ECSP961634A (en) 1996-01-09 1996-01-09 AGONISTS, ESTROGEN ANTAGONISTS

Publications (1)

Publication Number Publication Date
ECSP961634A true ECSP961634A (en) 1997-06-11

Family

ID=42042368

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961634 ECSP961634A (en) 1996-01-09 1996-01-09 AGONISTS, ESTROGEN ANTAGONISTS

Country Status (1)

Country Link
EC (1) ECSP961634A (en)

Similar Documents

Publication Publication Date Title
YU596A (en) Estrogen agonists/antagonists
HU0200264D0 (en) Estrogen agonists/antagonists for the treatment of certain cancers
CY1107862T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ESTEROL PRODUCERS FOR USE IN CANCER TREATMENT
ATE253039T1 (en) BETA 2 ADRENERGIC RECEPTOR AGONISTS
AP1869A (en) b2- Adrenergic receptor agonists.
EP2053129A8 (en) Method of diagnosing, monitoring, staging, imaging and treating various cancers
DE60040981D1 (en) TREATMENT WITH ANTI-ErbB2 ANTIBODIES
MY122020A (en) Use of gabab receptor agonists as reflux inhibitors
DE69942827D1 (en) USE OF EPOTHILONS FOR THE TREATMENT OF CANCER
DE69732868D1 (en) Remedy for itching
IL149402A0 (en) Arylamine derivatives and their use as anti-telomerase agent
ZA200003236B (en) Combination therapy for the treatment of migraine.
DE69823493D1 (en) TETRAHYDROPYRIDOVERBINDUNGEN
DZ2665A1 (en) Conjugates useful for the treatment of prostate cancer.
EA200200943A1 (en) HORMONAL THERAPY OF BREAST CANCER
ATE235483T1 (en) NEW CHALCHONE
DE69912477D1 (en) ENDOCRIN THERAPY FOR BREAST CANCER: COMBINED TAMOXIFE AND ALKYL PCDFS TREATMENT
ZA200002338B (en) Combination therapy for the treatment of migraine.
ZA200003235B (en) Combination therapy for the treatment of migraine.
WO2000036144A3 (en) Cancer diagnostic method using p40 subunit of eif3
AU2003212990A8 (en) Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
IT1314187B1 (en) Combination of different pharmaceutical compositions, useful for treating mammary carcinoma
RU98100756A (en) COPPER CEMENT MATERIAL
IT1313461B1 (en) MIXTURE FOR FRICTION MATERIALS FREE OF ASBESTOS, LEAD AND ZINC.
TH52877A3 (en) N- (3-ethylphenilaminos) -6,7-bis (2-methoxyethoxy) -4-quinazolinaminesmecylate an Hydrates and monohydrates